Chau Dang
0000-0001-5133-2265
3 papers found
Refreshing results…
Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Missing publications? Search for publications with a matching author name.